Role of the endocannabinoid system in MDMA intracerebral self‐administration in rats
- 1 August 2002
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 136 (8) , 1089-1092
- https://doi.org/10.1038/sj.bjp.0704825
Abstract
I.c.v. self‐administration of MDMA (0.01–2 μg per infusion), alone and in combination with CP 55,940 (0.4 μg infusion−1), was studied on an operant responding procedure. On the basis of individual preference for one of two levers, developed during training, rats were allowed to self‐administer vehicle from the preferred lever and MDMA from the other. Pressings on the MDMA associated‐lever, except for the maximal unit dose, progressively increased. The combination of CP 55,940 with MDMA (1 μg infusion−1) reduced the number of drug‐associated lever pressings compared to the single drugs. Pre‐treatment with SR 141716A (0.5 mg kg−1 i.p.), 15 min before each daily session, significantly increased MDMA self‐administration. These findings suggest that MDMA self‐administration is under endogenous tonic control by the endocannabinoid system.British Journal of Pharmacology (2002) 136, 1089–1092. doi:10.1038/sj.bjp.0704825Keywords
This publication has 23 references indexed in Scilit:
- Marijuana and cannabinoid regulation of brain reward circuitsBritish Journal of Pharmacology, 2004
- Intravenous self-administration of the cannabinoid CB1 receptor agonist WIN 55,212-2 in ratsPsychopharmacology, 2001
- Δ9‐tetrahydrocannabinol releases and facilitates the effects of endogenous enkephalins: reduction in morphine withdrawal syndrome without change in rewarding effectEuropean Journal of Neuroscience, 2001
- Enhancement of Anandamide Formation in the Limbic Forebrain and Reduction of Endocannabinoid Contents in the Striatum of Δ9‐Tetrahydrocannabinol‐Tolerant RatsJournal of Neurochemistry, 2000
- Toxicity of drug abuse — amphetamine designer drugs (ecstasy): mental effects and consequences of single dose useToxicology Letters, 2000
- Cannabinoid Transmission and Reward-Related EventsNeurobiology of Disease, 1998
- Naltrindole, a δ-opioid antagonist, blocks MDMA's ability to enhance pressing for rewarding brain stimulationPharmacology Biochemistry and Behavior, 1996
- Methylenedioxymethamphetamine's capacity to establish place preferences and modify intake of an alcoholic beveragePharmacology Biochemistry and Behavior, 1990
- Self-injection of d,1-3,4-methylenedioxymethamphetamine (MDMA) in the baboonPsychopharmacology, 1987
- Self-administration of methylenedioxymethamphetamine (MDMA) by rhesus monkeysDrug and Alcohol Dependence, 1986